Never Run Out Of Buyers To Sell To.

Adicet Bio, Inc.(Nasdaq: ACET) is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. For more information, please visit our website at Your safety as a job seeker matters to us. Please be cautious of fraudulent recruitment activity claiming to represent Adicet. All approved positions are accessible via the Adicet Careers page at
Annual Revenue$50M to $100M
Estimated OwnershipPublicBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.